Vancomycin dosing for pneumonia in critically ill trauma patients

Journal of Trauma - Injury, Infection and Critical Care

Volumn 67, Issue 4, 2009, Pages 802-804

  Patanwala, Asad E ^a   Norris, Christopher J ^b   Nix, David E ^a   Kopp, Brian J ^c   Erstad, Brian L ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^c UNIVERSITY OF ARIZONA MEDICAL CENTER   (United States)

Author keywords

Kinetics; Pneumonia; Trauma; Vancomycin

Indexed keywords

VANCOMYCIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CRITICALLY ILL PATIENT; DEMOGRAPHY; DOSAGE SCHEDULE COMPARISON; DRUG CONCENTRATION; DRUG DOSE REGIMEN; FEMALE; HUMAN; INJURY; INTENSIVE CARE UNIT; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; PNEUMONIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STEADY STATE; STUDENT T TEST;

ADULT; ANTI-BACTERIAL AGENTS; COMORBIDITY; CRITICAL ILLNESS; CROSS INFECTION; FEMALE; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; PNEUMONIA, STAPHYLOCOCCAL; VANCOMYCIN; WOUNDS AND INJURIES;

EID: 72449211109     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/TA.0b013e31818e90d2     Document Type: Article

References (9)

1. Varez-Lerma F, Grau S, Gracia-Arnillas MP. Gram-positive cocci infections in intensive care: guide to antibacterial selection. Drugs. 2006;66:751-768.
2. National Nosocomial Infections Surveillance (NNIS) System. Report, data summary from January 1992 through June 2003, issued August 2003. Am J Infect Control. 2003;31:481-498.
3. American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator- associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171:388-416.
4. Moise-Broder PA, Forrest A, Birmingham MC, Schentag JJ. Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections. Clin Pharmacokinet. 2004;43:925-942.
5. Georges H, Leroy O, Alfandari S, et al. Pulmonary disposition of vancomycin in critically ill patients. Eur J Clin Microbiol Infect Dis. 1997;16:385-388.
6. Lamer C, de B V, Soler P, et al. Analysis of vancomycin entry into pulmonary lining fluid by bronchoalveolar lavage in critically ill patients. Antimicrob Agents Chemother. 1993;37:281-286.
7. Barletta JF, Johnson SB, Nix DE, Nix LC, Erstad BL. Population pharmacokinetics of aminoglycosides in critically ill trauma patients on once-daily regimens. J Trauma. 2000;49:869-872.
8. Roberts JA, Lipman J. Antibacterial dosing in intensive care: pharmacokinetics, degree of disease and pharmacodynamics of sepsis. Clin Pharmacokinet. 2006;45:755-773.
9. Hidayat LK, Hsu DI, Quist R, Shriner KA, Wong-Beringer A. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity. Arch Intern Med. 2006;166:2138-2144.